Treating depression in diabetic patients: Latihan pasrah diri (LPD) revisited

Agus Siswanto; Arief Kurniawan Siregar; Ahmad Husain Asdie

doi:10.22146/actainterna.27007

Treating depression in diabetic patients: Latihan pasrah diri (LPD) revisited

https://doi.org/10.22146/actainterna.27007

Agus Siswanto^(1*), Arief Kurniawan Siregar⁽²⁾, Ahmad Husain Asdie⁽³⁾

(1)
(2)
(3)
(*) Corresponding Author

Abstract

The condition accompanying depression will always be progressing into poor prognosis if the depression itself is not recognized and treated properly. Among diabetic patients, depression was associated with increased mortality and poor quality of life . It was observed that diabetes and depression has a bidirectional relationship, where the clinical course of both conditions are affecting each other. Despite the effectiveness of psychological and psychopharmacological interventions in treating depressive symptoms in diabetic patients, the effect of such interventions on glycemic control is still inconsistent. Complementary alternative medicine (CAM) alone or in combination with standard medical treatment, targeting both depression and diabetes, appears to be promising. Latihan Pasrah Diri (LPD) has been recognized as a type of relaxation technique under CAM. It is initially directed to provide adequate relieve of depression using both religious and relaxative approach. Among patients with comorbid diabetes and depression, this approach has long been known and utilized over the counter, but its formal practice is seldom advocated, whereas, many clinical trials has been conducted locally to reveal its potential use. Combined with standard therapy, LPD is expected to show its beneficial effects.

Keywords

depression, diabetes, complementary alternative medicine, latihan pasrah diri

Full Text:

PDF

References

Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes. A metaanalysis. 2001;24(6):1069-78.

Knol MJ, Twisk JWR, Beekman ATF, Heine RJ, Snoek FJ, Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia. 2006;49(5):837-45.

Chen P-C, Chan Y-T, Chen H-F, Ko M-C, Li C-Y. Population-based cohort analyses of the bidirectional relationship between type 2 diabetes and depression. Diabetes Care. 2013;36(2):376-82.

Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: A meta-analysis. Diabetes Care. 2008;31(12):2383- 90.

Lustman PJ, Griffith LS, Gavard JA, Clouse RE. Depression in adults with diabetes. Diabetes care. 1992;15(11):1631-9.

Kawakami N, Takatsuka N, Shimizu H, Ishibashi H. Depressive symptoms and occurrence of type 2 diabetes among japanese men. Diabetes Care. 1999;22(7):1071-6.

Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE. Depression and risk for onset of type II diabetes: A prospective population-based study. Diabetes Care. 1996;19(10):1097-102.

Strine TW, Mokdad AH, Dube SR, Balluz LS, Gonzalez O, Berry JT, et al. The association of depression and anxiety with obesity and unhealthy behaviors among community-dwelling us adults. General Hospital Psychiatry. 2008;30(2):127-37.

Weber B, Schweiger U, Deuschle M, Heuser I. Major depression and impaired glucose tolerance. Exp Clin Endocrinol Diabetes. 2000;108(3):187- 90.

Golden SH. A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus. Current Diabetes Reviews. 2007;3(4):252-9.

Cradock S, Skinner C. Counselling and relaxation therapies. In: Dunning T, editor. Complementary therapies and the management of diabetes and vascular disease. 1 ed. Cippenham, Wiltshire, Great Britain: John Wiley & Sons Ltd; 2006. p. 161-3.

Barnard KD, Skinner TC, Peveler R. The prevalence of co-morbid depression in adults with type 1 diabetes: Systematic literature review. Diabetic Medicine. 2006;23(4):445-8.

Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of co-morbid depression in adults with type 2 diabetes: A systematic review and meta-analysis. Diabet Med. 2006;23.

Katon WJ, Rutter C, Simon G, Lin EHB, Ludman E, Ciechanowski P, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care. 2005;28(11):2668-72.

de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: A meta-analysis. Psychosomatic Medicine. 2001;63(4):619-30.

Zhang X, Norris SL, Gregg EW, Cheng YJ, Beckles G, Kahn HS. Depressive symptoms and mortality among persons with and without diabetes. American Journal of Epidemiology. 2005;161(7):652-60.

Goldney RD, Phillips PJ, Fisher LJ, Wilson DH. Diabetes, depression, and quality of life. A population study. 2004;27(5):1066-70.

Saatci E, Tahmiscioglu G, Bozdemir N, Akpinar E, Ozcan S, Kurdak H. The well-being and treatment satisfaction of diabetic patients in primary care. Health and Quality of Life Outcomes. 2010;8(1):1-8.

Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T. How to screen for depression and emotional problems in patients with diabetes: Comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia.

;49(3):469-77.

Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, et al. Assessing psychosocial distress in diabetes. Development of the Diabetes Distress Scale. 2005;28(3):626-31.

Bassett J, Adelman A, Gabbay R, Aňel- Tiangco RM. Relationship between depression and treatment satisfaction among patients with type 2 diabetes. Journal of diabetes & metabolism. 2012;3(7):1000210.

Gonzalez JS, Peyrot M, McCarl LA, Collins EM, Serpa L, Mimiaga MJ, et al. Depression and diabetes treatment nonadherence: A meta-analysis. Diabetes Care. 2008;31(12):2398-403.

Schmitt A, Reimer A, Kulzer B, Haak T, Gahr A, Hermanns N. Assessment of diabetes acceptance can help identify patients with ineffective diabetes self-care and poor diabetes control. Diabetic Medicine. 2014;31(11):1446-51.

Howren MB, Lamkin DM, Suls J. Associations of depression with c-reactive protein, il-1, and il-6: A meta-analysis. Psychosomatic Medicine. 2009;71(2):171-86.

Hood KK, Lawrence JM, Anderson A, Bell R, Dabelea D, Daniels S, et al. Metabolic and inflammatory links to depression in youth with diabetes. Diabetes Care. 2012;35(12):2443-6.

Laake J-PS, Stahl D, Amiel SA, Petrak F, Sherwood RA, Pickup JC, et al. The association between depressive symptoms and systemic

inflammation in people with type 2 diabetes: Findings from the south london diabetes study. Diabetes Care. 2014;37(8):2186-92.

Herder C, Carstensen M, Ouwens DM. Antiinflammatory cytokines and risk of type 2 diabetes. Diabetes, Obesity and Metabolism. 2013;15(s3):39-50.

Petrak F, Herpertz S, Albus C, Hermanns N, Hiemke C, Hiller W, et al. Cognitive behavioral therapy versus sertraline in patients with depression and poorly controlled diabetes: The diabetes and depression (dad) study. A Randomized Controlled Multicenter Trial.

;38(5):767-75.

Hermanns N, Schmitt A, Gahr A, Herder C, Nowotny B, Roden M, et al. The effect of a diabetes-specific cognitive behavioral treatment program (diamos) for patients with diabetes and subclinical depression: Results of a randomized controlled trial. Diabetes Care. 2015;38(4):551-60.

Safren SA, Gonzalez JS, Wexler DJ, Psaros C, Delahanty LM, Blashill AJ, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (cbt-ad) in patients

with uncontrolled type 2 diabetes. Diabetes Care. 2014;37(3):625-33.

Bogner HR, Morales KH, de Vries HF, Cappola AR. Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: A randomized controlled trial. Annals of Family Medicine. 2012;10(1):15-22.

Huang Y, Wei X, Wu T, Chen R, Guo A. Collaborative care for patients with depression and diabetes mellitus: A systematic review and meta-analysis. BMC Psychiatry. 2013;13(1):1-11.

Goodnick PJ. Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Annals of Clinical Psychiatry. 2001;13(1):31-41.

Astin JA. Why patients use alternative medicine: Results of a national study. JAMA. 1998;279(19):1548-53.

Pfeifer S. Alternative heilmethoden bei psychischen erkrankungen. Basel, SUISSE: Schwabe & amp Co; 1993.

Sabo CE, Michael SR, Temple LL. The use of alternative therapies by diabetes educators. The Diabetes Educator. 1999;25(6):945-56.

Pawa M. Complementary therapy use. In: Dunning T, editor. Complementary therapies and the management of diabetes and vascular disease. 1 ed. Cippenham, Wiltshire, Great Britain: John Wiley & Sons Ltd; 2006. p. 24-5.

Leese GP, Gill GV, Houghton GM. Prevalence of complementary medicine usage within a diabetes clinic. Practical Diabetes International. 1997;14(7):207-8.

Egede LE, Ye X, Zheng D, Silverstein MD. The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care. 2002;25(2):324-9.

Dharma AD. Pengaruh latihan pasrah diri terhadap kontrol gula darah pada penderita diabetes melitus tipe 2 dengan gejala depresi [Thesis]. Yogyakarta: Gadjah Mada University; 2006.

Petrak F, Herpertz S. Treatment of depression in diabetes: An update. Current Opinion in Psychiatry. 2009;22(2):211-7.

Markowitz S, Gonzalez JS, Wilkinson JL, Safren SA. Treating depression in diabetes: Emerging findings. Psychosomatics. 2011;52(1):1-18.

Stoop CH, Nefs G, Pommer AM, Pop VJM, Pouwer F. Effectiveness of a stepped care intervention for anxiety and depression in people

with diabetes, asthma or copd in primary care: A randomized controlled trial. Journal of Affective Disorders. 2015;184:269-76.

Williams JJW, Katon W, Lin EHB, No el PH, Worchel J, Cornell J, et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Annals of Internal Medicine. 2004;140(12):1015-24.

Katon WJ, Von Korff M, Lin EH, Simon G, Ludman E, Russo J, et al. The pathways study: A randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry. 2004;61.

Stiefel F, Zdrojewski C, Bel Hadj F, Boffa D, Dorogi Y, So A, et al. Effects of a multifaceted psychiatric intervention targeted for the complex medically ill: A randomized controlled trial. Psychotherapy and Psychosomatics. 2008;77(4):247-56.

Bogner HR, Morales KH, Post EP, Bruce ML. Diabetes, depression, and death. A randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT). 2007;30(12):3005-10.

Gois C, Dias VV, Carmo I, Duarte R, Ferro A, Santos AL, et al. Treatment response in type 2 diabetes patients with major depression. Clinical Psychology & Psychotherapy. 2014;21(1):39-48.

Archer J, Bower P, Gilbody S, Lovell K, Richards D, Gask L, et al. Collaborative care for depression and anxiety problems. Cochrane

database syst rev 2012.

Katon WJ, Lin EHB, Korff MV, Ciechanowski P, Ludman EJ, Young B, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363.

Lamers F, Jonkers CCM, Bosma H, Knottnerus JA, van Eijk JTM. Treating depression in diabetes patients: Does a nurseadministered minimal psychological intervention affect diabetes-specific quality of life and glycaemic control? A randomized controlled trial. Journal of Advanced Nursing. 2011;67(4):788-99.

Mocking RJT, Assies J, Bot M, Jansen EHJM, Schene AH, Pouwer F. Biological effects of addon eicosapentaenoic acid supplementation in

diabetes mellitus and co-morbid depression: A randomized controlled trial. PLoS ONE. 2012;7(11):e49431.

Pibernik-Okanović M, Hermanns N, Ajduković D, Kos J, Prašek M, Šekerija M, et al. Does treatment of subsyndromal depression

improve depression-related and diabetes-related outcomes? A randomised controlled comparison of psychoeducation, physical exercise and enhanced treatment as usual. Trials. 2015;16:305.

The Look ARG. Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: The look ahead trial. Diabetes Care. 2014;37(6):1544-53.

Baumeister H, Nowoczin L, Lin J, Seifferth H, Seufert J, Laubner K, et al. Impact of an acceptance facilitating intervention on diabetes

patients; 2019; acceptance of internet-based interventions for depression: A randomized controlled trial. Diabetes Research and Clinical Practice.105(1):30-9.

Amsterdam JD, Shults J, Rutherford N, Schwartz S. Safety and efficacy of s-citalopram in patients with co-morbid major depression and diabetes mellitus. Neuropsychobiology. 2006;54(4):208-14.

Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Fluoxetine for depression in diabetes: A randomized double-blind placebo-controlled trial. Diabetes Care. 2000;23(5):618-23.

Paile-Hyvärinen M, Wahlbeck K, Eriksson JG. Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: A double-blind randomised placebo controlled 6-month trial. BMC Family Practice. 2007;8(1):1-7.

Lustman PJ, Clouse RE, Nix BD, et al. Sertraline for prevention of depression recurrence in diabetes mellitus: A randomized, double-blind, placebo-controlled trial. Archives of General Psychiatry. 2006;63(5):521-9.

Karaiskos D, Tzavellas E, Ilias I, Liappas I, Paparrigopoulos T. Agomelatine and sertraline for the treatment of depression in type 2 diabetes mellitus. International Journal of Clinical Practice.

;67(3):257-60.

Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, et al. Effects of nortriptyline on depression and glycemic

control in diabetes: Results of a double-blind, placebo-controlled trial. Psychosomatic Medicine. 1997;59(3):241-50.

Biagetti B, Corcoy R. Hypoglycemia

associated with fluoxetine treatment in a patient with type 1 diabetes. World Journal of Clinical Cases : WJCC. 2013;1(5):169-71.

Goodnick PJ, Kumar A, Henry JH, Buki VM, Goldberg RB. Sertraline in coexisting major depression and diabetes mellitus. Psychopharmacol Bull. 1997;33.

Warnock JK, Biggs F. Nefazodone-induced hypoglycemia in a diabetic patient with major depression. The American Journal of Psychiatry. 1997;154(2):288-9.

Adnitt PI. Hypoglycemic action of monoamineoxidase inhibitors (maoi's). Diabetes. 1968;17(10):628-33. 66. Isotani H, Kameoka K. Hypoglycemia associated with maprotiline in a patient with type 1 diabetes. Diabetes Care. 1999;22(5):862-3.

Pollak PT, Mukherjee SD, Fraser AD. Sertraline-induced hypoglycemia. Annals of Pharmacotherapy. 2001;35(11):1371-4.

Lustman PJ, Williams MM, Sayuk GS, Nix BD, Clouse RE. Factors influencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropion. Diabetes Care. 2007;30(3):459-66.

Rubin RR, Ma Y, Marrero DG, Peyrot M, Barrett-Connor EL, Kahn SE, et al. Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care. 2008;31(3):420-6.

Rubin RR, Gaussoin SA, Peyrot M, DiLillo V, Miller K, Wadden TA, et al. Cardiovascular disease risk factors, depression symptoms and

antidepressant medicine use in the look ahead (action for health in diabetes) clinical trial of weight loss in diabetes. Diabetologia.

;53(8):1581-9.

WHO. Who traditional medicine strategy 2002–2005. Geneva: WHO, 2002.

Vickers A. Massage and aromatherapy: A guide for health professionals. 1st ed. London: Chapman and Hall; 1996.

Ernst E, Rand JI, Stevinson C. Complementary therapies for depression: An overview. Archives of General Psychiatry. 1998;55(11):1026-32.

Stenström U, Göth A, Carlsson C, Andersson P-O. Stress management training as related to glycemic control and mood in adults with type 1 diabetes mellitus. Diabetes Research and Clinical

Practice. 2003;60(3):147-52.

Surwit RS, van Tilburg MAL, Zucker N, McCaskill CC, Parekh P, Feinglos MN, et al. Stress management improves long-term glycemic control in type 2 diabetes. Diabetes Care. 2002;25(1):30-4.

Aviles JM, Whelan SE, Hernke DA, Williams BA, Kenny KE, O'Fallon WM, et al. Intercessory prayer and cardiovascular disease progression in a coronary care unit population: A randomized controlled trial. Mayo Clinic Proceedings. 2001;76(12):1192-8.

Lorig KR, Ritter PL, Laurent DD, Fries JF. Long-term randomized controlled trials of tailored-print and small-group arthritis selfmanagement interventions. Medical Care. 2004;42(4):346-54.

Muin N. Pengaruh latihan pasrah diri (lpd) ditambah fluoxetin dibanding fluoxetin terhadap penurunan kadar fruktosamin penderita pengidap diabetes melitus tipe 2 dengan simtom depresi [Thesis]. Yogyakarta: Gadjah Mada University; 2015.

Rudiansyah M. Pengaruh latihan pasrah diri terhadap kadar c-reactive protein pada penderita diabetes mellitus tipe 2 dengan gejala depresi [Thesis]. Yogyakarta: Gadjah Mada University; 2008.

Kusbandono S. Pengaruh kombinasi latihan pasrah diri dan fluoxetin dibandingkan dengan fluoxetin tunggal terhadap perubahan kadar high sensitivity c-reactive protein: Studi pada penderita diabetes melitus tipe 2 dengan simtom depresi [Thesis]. Yogyakarta: Gadjah Mada University; 2015.

Widodo T. Pengaruh latihan pasrah diri terhadap angka lekosit pada penderita diabetes melitus tipe 2 dengan gejala depresi [Thesis]. Yogyakarta: Gadjah Mada University; 2008.

Kurnianingrum NMA. Pengaruh kombinasi latihan pasrah diri dan fluoxetin dibandingkan dengan fluoxetin tunggal terhadap perubahan kadar endothelin-1 : Studi pada penderita diabetes melitus tipe 2 dengan simtom depresi [Thesis]. Yogyakarta: Gadjah Mada University; 2015.

Sari W. Pengaruh kombinasi latihan pasrah diri dan fluoxetin dibandingkan dengan fluoxetin tunggal terhadap perubahan kadar oksida nitrit : Studi pada penderita diabetes melitus tipe 2 dengan simtom depresi. [Thesis]. In press 2016.

Novianto D. Pengaruh latihan pasrah diri terhadap kontrol tekanan darah penderita diabetes melitus tipe 2 dengan hipertensi dan gejala depresi [Thesis]. Yogyakarta: Gadjah Mada University;

Hidayat N. Pengaruh latihan pasrah diri terhadap kualitas hidup pada penderita diabetes melitus tipe 2 dengan gejala depresi [Thesis]. Yogyakarta: Gadjah Mada University; 2008.

Astin JA, Shapiro SL, Eisenberg DM, Forys KL. Mind-body medicine: State of the science, implications for practice. The Journal of the American Board of Family Practice. 2003;16(2):131-47.

Zalaquett CP, McGraw A. Clinician's complete reference to complementary/alternative medicine. Novey D, editor. New York: Mosby; 2000. 114-29 p.

DOI: https://doi.org/10.22146/actainterna.27007